Abstract:Tuberculosis (TB) is a life-threatening disease resulting in an estimated 10 million new infections and 1.8 million deaths annually, primarily in underdeveloped countries. The economic burden of TB has been estimated as approximately 12 billion USD annually in direct and indirect costs. Additionally, multi-drug-resistant (MDR) and extreme-drug-resistant (XTR) TB strains resulting in about 250 000 deaths annually are now widespread, increasing pressure on the identification of new anti-TB agents that operate by a novel mechanism of action. Chrysomycin A is a rare C-aryl glycoside first discovered over 60 years ago. In a recent high-throughput screen, we found that chrysomycin A has potent anti-TB activity, with minimum inhibitory concentration (MIC) = 0.4 pg/mL against MDR-TB strains. However, chrysomycin A is obtained in low yields from fermentation of Streptomyces, and the mechanism of action of this compound is unknown. To facilitate the mechanism of action and preclinical studies of chrysomycin A, we developed a 10-step, scalable synthesis of the isolate and its two natural congeners polycarcin V and gilvocarcin V. The synthetic sequence was enabled by the implementation of two sequential C-H functionalization steps as well as a late-stage C-glycosylation. In addition, >10 g of the advanced synthetic intermediate has been prepared, which greatly facilitated the synthesis of 33 new analogues to date. The structure-activity relationship was subsequently delineated, leading to the identification of derivatives with superior potency against MDR-TB (MIC = 0.08 mu g/mL). The more potent derivatives contained a modified carbohydrate residue which suggests that further optimization is additionally possible. The chemistry we report here establishes a platform for the development of a novel class of anti-TB agents active against drug-resistant pathogens.

Abyssomicins from the South China Sea Deep‐Sea Sediment Verrucosispora Sp.: Natural Thioether Michael Addition Adducts As Antitubercular Prodrugs

A New Abyssomicin Polyketide with Anti-Influenza A Virus Activity from a Marine-Derived Verrucosispora Sp. MS100137

Review on Abyssomicins: Inhibitors of the Chorismate Pathway and Folate Biosynthesis

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

Novel 1-Benzoazepine-Derived Michael Acceptor and Its Hetero-Adducts Active Against MRSA

Anti-MRSA and anti-TB metabolites from marine-derived Verrucosispora sp. MS100047

LC-MS guided discovery of a new type of abyssomicin, glycoabyssomicin A, from a deep-sea derived Streptomyces

New Polyene Macrolide Compounds from Mangrove-Derived Strain Streptomyces hiroshimensis GXIMD 06359: Isolation, Antifungal Activity, and Mechanism against Talaromyces marneffei

Tetrachloromaxamycins: Divergent Total Synthesis and Initial Assessments

Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces Scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria

Secondary metabolites from the deep-sea derived fungus Aspergillus terreus MCCC M28183

Discovery of Amphiphilic Xanthohumol Derivatives As Membrane-Targeting Antimicrobials Against Methicillin-Resistant Staphylococcus Aureus.

-Aminooxyacetic acid derivatives acting as pro-drugs against

Chrysomycin A Derivatives for the Treatment of Multi-Drug-Resistant Tuberculosis.

Sesterterpenes and macrolide derivatives from the endophytic fungus Aplosporella javeedii

New capoamycin-type antibiotics and polyene acids from marine Streptomyces fradiae PTZ0025

Discovery of novel secondary metabolites from the basidiomycete Lentinus cf. sajor-caju and their inhibitory effects on Staphylococcus aureus biofilms

The Discovery of Weddellamycin, a Tricyclic Polyene Macrolactam Antibiotic from an Antarctic Deep-Sea-Derived <i>Streptomyces</i> sp. DSS69, by Heterologous Expression

Polyketides with potential bioactivities from the mangrove-derived fungus Talaromyces sp. WHUF0362

Antimicrobial sesterterpenoids with a unique 5/8/6/5 tetracyclic carbon-ring-system and diepoxide polyketides from a deep sea-sediment-sourced fungus Chaetomium globosum SD-347

A Pimarane Diterpene and Cytotoxic Angucyclines from a Marine-Derived Micromonospora sp. in Vietnam’s East Sea